DexCom (NAS: DXCM) reported earnings on Nov. 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), DexCom met expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP loss per share grew.
Margins dropped across the board.
DexCom booked revenue of $23.1 million. The 12 analysts polled by S&P Capital IQ foresaw revenue of $23.0 million on the same basis. GAAP reported sales were 26% higher than the prior-year quarter's $18.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.15. The nine earnings estimates compiled by S&P Capital IQ predicted -$0.19 per share. GAAP EPS were -$0.25 for Q3 against -$0.20 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 36.4%, 830 basis points worse than the prior-year quarter. Operating margin was -75.0%, 210 basis points worse than the prior-year quarter. Net margin was -74.8%, 210 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $27.4 million. On the bottom line, the average EPS estimate is -$0.17.
Next year's average estimate for revenue is $93.8 million. The average EPS estimate is -$0.78.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 76 members out of 173 rating the stock outperform, and 97 members rating it underperform. Among 64 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 22 give DexCom a green thumbs-up, and 42 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DexCom is outperform, with an average price target of $14.43.
Add DexCom to My Watchlist.
The article DexCom Beats Up on Analysts Yet Again originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.